RUDN University journals «Vestnik RUDN» entered TOP-100 best Russian scientific journals
RUDN University journals «Vestnik RUDN» entered TOP-100 best Russian scientific journals
2,856 scientific journals participated in a joint contest held by the RF Ministry of education and science and NEICON non-profit partnership.

The journals were assessed according to more than 30 criteria depending on thematic relevance in the world research community.

Two RUDN journals are among TOP-100:

«RUDN Vestnik. Series: Agronomy and animal industries» (Chief editor V.Plyuschikov)

«RUDN Vestnik. Series: Political science» (Chief editor Yu.Pochta)

The contest is aimed at supporting scientific journals to help them enter international scientometric databases.

Read more


All news
20 Oct
RUDN chemist created an efficient catalyst for organic sulfides synthesis

A RUDN chemist has obtained a new compound — a dumbbell-shaped phosphate-bridged molybdenum cluster. The cluster accelerates the reaction of the formation of sulfides from oxides and can be used in pharmaceutical and cosmetic manufacturing.

19 Oct
RUDN University mathematicians created a method for study the properties of porous materials

Mathematicians from RUDN University have studied the properties of compositional operators in spaces with mixed Lebesgue norms. It will help describe the diffusion of liquids in materials with cracks and in porous materials. Such spaces are also useful for obtaining estimates for solutions to the Navier-Stokes equation.

09 Oct
RUDN University biophysicist modelled the behaviour of cell microtubule elements to chemically affect their growth and decay

A biophysicist from RUDN University and his colleagues modelled the molecular dynamics of growth of microtubules, the most important elements of cell activity. The researchers have built a model for the interaction of microtubule subunits, which takes into account their internal and external connections. The results will help form a more complete model of the dynamic instability of microtubules. It will allow choosing chemical agents for the treatment of certain diseases, including neoplasms and neurodegenerative pathologies.